Thymosin Beta
Thymosin Beta comes from the thymus gland. There are over 15 types of Thymosin Beta with Beta 4 being one of three found in the body. The other two are Beta 10 and 15.
Thymosin Beta 4 is also the more popular peptide. It accounts for about 70% – 80% of this range of peptides.
Besides the thymus gland, you can find Tꞵ4 in the spleen and certain white blood cells.
This small peptide comprises 43 amino acids. A few of them regulate the anti-inflammatory and antifibrotic effects. Fifteen of them help alleviate toxicity in damaged cells.
Another couple activates the angiogenesis process. They also trigger the growth of hair follicles.
Thymosin Beta 4 is a multifunctional peptide that helps heal and restore a range of medical conditions.
- Free shipping over $100
- US compounding Pharmacy
- Privacy Guarantee
Product details
Thymosin helps in forming antibodies that aid a strong immune system. A hormone secreted by the thymus gland. Known as a multifunctional peptide. Plays a significant role in the physiological and pathological processes.
The peptide has both an alpha and beta option. The former focuses on improving the immune system. The latter does a little more. It helps regulate your immunity, repairs tissue, and eases joint pain.
You will find Thymosin beta in various parts of the body. In fluids, tissue, and inside cells. Tꞵ4 occurs naturally and is water soluble.
It has regenerative properties and, when attached to actin, promotes cell migration. It helps form new blood vessels and tissue.
Wound repair is one of the key benefits of this peptide. It does this by contracting the outer ridges of the scar area.
Thymosin Beta also reduces the visible appearance of scars. Accelerating the process of fibrosis. Many use it for dermal healing.
Tꞵ4 increases the immune system cells and decreases inflammatory substances.
Applications
Research indicates that Thymosin ꞵ4 has a positive effect on the body’s immune system. It attaches to toxins and expels any foreign bodies.
Tꞵ4 may alleviate cardiovascular conditions and improve the health of your heart. However, it may not repair tissue damage resulting from a heart attack.
Thymosin beta 4 can assist with restoring tissue after muscle or tendon injuries. It can even ease muscular spasms.
The peptide also helps by stimulating T cells. These white blood cells, part of the immune system, help protect the body from infection. It may also help fight cancer, regulating cell migration.
As this action assists with the autoimmune, it reduces hypertension. A study showed an improvement in glucose intolerance. This change reflects it as a potential alternative treatment of type 2 diabetes.
Other reports have also found Thymosin ꞵ4 to stimulate hair growth. It does this by stimulating the follicles and accelerates the development.
Thymosin ꞵ4, when administered as optic drops may ease dry eyes. The treatment resulted in significant improvement. Research conducted showed an increase in tear production.
The peptide acts as a corneal anti-inflammatory as well as a healing agent. The effects extend beyond the course of treatment.
This action is also a result of tissue generation. The regeneration process extends to the health of the brain, too. Improving the density of axons and nerve cell formation.
Further research conducted on rodents with kidney injury showed positive results. Exogenous Tꞵ4 in human physiology may ease the advancement of chronic kidney disease. It could delay the transition to end-stage kidney disease.
Other uses of Tꞵ4 includes:
- Neuroinflammation
- Spinal cord injuries
- Sport injuries
- Eye infirmities
- Diabetes
- Lung inflammation
- Others
Thymosin ꞵ4’s impact on non-alcoholic fatty liver disease (NAFLD), requires more research. Experts, however, believe this peptide has sufficient potential therapeutic benefits to treat it.
The way Tꞵ4 helps hepatic stem cell activation suggests it may help treat liver disease.
Thymosin beta, however, may not cure or treat any disease. Always consult a medical professional before commencing any treatment. Report any signs of adverse effects immediately to a health practitioner.
Safety and side effects
In research settings, Thymosin Beta-4 is generally considered safe when used within recommended dosages.
Minor adverse effects have been observed, including:
- Nausea
- Fatigue
- Headache
- Dizziness
- Lethargy
Injection of Thymosin Beta-4 may lead to local irritation at the injection site, and some studies have reported joint discomfort following therapy. Currently, there is insufficient data on the safety of Thymosin Beta-4 for pediatric use.
For research purposes, proper storage is crucial to maintain peptide stability. Thymosin Beta-4 should be kept in cool, dry conditions, away from bright light. It should be stored at temperatures between 2°C and 8°C for short-term use, and at -20°C for long-term storage.
Once reconstituted, it should be stored at -20°C to -80°C. Avoid repeated thawing and refreezing to prevent degradation. Always use chemically inert storage containers such as glass or plastic, with polypropylene being a durable choice.
Proper handling ensures the integrity of the peptide for accurate research outcomes.
Frequently asked questions
Do you still have a few unanswered questions? Consider the following FAQs that many others have asked:
In which forms is Thymosin Beta-4 available?
Thymosin Beta-4 is typically available for research as an injectable peptide, administered subcutaneously. Research protocols often involve daily injections, but usage is generally limited to cycles of 6 weeks on, followed by 6 weeks off. This approach helps to assess the peptide's effects and minimize potential risks.
How long does it take for Thymosin Beta-4 to show effects?
The timeframe for observing results from Thymosin Beta-4 can vary. Research protocols commonly span 4 to 12 weeks. Adhering to the prescribed dosage and duration is crucial. Effects may start to become evident within this period depending on the specific research objectives and conditions.
Is Thymosin Beta-4 safe for pregnant subjects in research?
Current research on Thymosin Beta-4 in pregnant subjects is limited. Some studies suggest potential benefits in fetal growth and tissue development.
There is insufficient evidence to fully establish its safety and efficacy during pregnancy. Researchers should exercise caution and consult relevant guidelines before considering any studies involving pregnant subjects.